Therapy News and Research

RSS

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

In a phase 3 trial, once-daily oral orforglipron induced significant, dose-dependent weight loss over 72 weeks in adults with obesity but no diabetes. It also improved multiple cardiometabolic markers with a safety profile similar to other GLP-1 receptor agonists.

18 Sep 2025

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

A new clinical trial has revealed encouraging results for a muscle-targeting therapy aimed at improving motor function in children and adolescents with spinal muscular atrophy, according to a study published in The Lancet Neurology.

18 Sep 2025

Investigational drug reduces hot flashes and night sweats for post-menopausal women

The investigational drug elinzanetant significantly reduces hot flashes and night sweats for post-menopausal women, a large, international clinical trial has found.

18 Sep 2025

Massage Therapy Foundation funds CHOP study on pediatric irritable bowel syndrome

The Massage Therapy Foundation (MTF) announces the award of a research grant to Children's Hospital of Philadelphia (CHOP). The grant will support a three-year study entitled Myofascial Release Therapy in Irritable Bowel Syndrome led by Primary Investigators Maria Mascarenhas, MBBS and Alain J. Benitez, MD, MSTR.

18 Sep 2025

Music therapy improves patient experience and outcomes in the cardiac ICU

Music therapy could significantly reduce heart rate, blood pressure and patient–ventilator asynchronies for patients admitted to the cardiac intensive care unit (ICU), according to research being presented at ACC Latin America 2025 taking place September 18-20 in Mexico City.

18 Sep 2025

New study uncovers why dispersed glioblastoma cells are more dangerous

A new study, led by researchers at Sylvester Comprehensive Cancer Center part of the University of Miami Miller School of Medicine, captured details of glioblastoma that had never before been seen and revealed a surprise finding: Glioblastoma cells that "cluster" together with other cells of the same type are less deadly than those that disperse from these clusters.

18 Sep 2025

University of Houston co-leads national study on atropine eyedrops for nearsightedness prevention

The University of Houston is co-leading a national study, the first of its kind in the United States, exploring whether atropine eyedrops can delay the onset of nearsightedness in young children and lessen its progression over a lifetime, a project with potential to shape future standards in vision care.

18 Sep 2025

New molecule offers a more targeted and potent immunotherapy

A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and University Hospital Basel, Switzerland, have demonstrated that this fusion protein can both block the "do not attack" signal used by cancer cells and selectively activate tumor-fighting immune cells. This dual action could pave the way for more effective cancer therapies with fewer side effects.

18 Sep 2025

Targeted radiation shows promise for rare solitary fibrous tumors

A novel targeted radiation approach for a rare form of malignant tumor-the solitary fibrous tumor (SFT)-has shown significant success, achieving a near-complete response in three patients.

17 Sep 2025

Implantable device helps stabilize blood pressure in spinal cord injury patients

Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs.

17 Sep 2025

Psoriasis linked to higher risk of age-related macular degeneration

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), a leading cause of vision loss.

17 Sep 2025

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

17 Sep 2025

The 15th AACR cancer progress report highlights scientific advances

The American Association for Cancer Research (AACR) released the 15th edition of its annual Cancer Progress Report. A cornerstone of the AACR's educational and advocacy efforts, this comprehensive report provides the latest statistics on cancer incidence, mortality, and survivorship and highlights how federal investments in basic, translational, and clinical cancer research and cancer-related population sciences have led to impressive scientific advances that are improving health and saving lives.

17 Sep 2025

The mind-gut connection: How emotional eating affects GLP-1 drug success

GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes - helping stabilize blood glucose and lose weight which contributes to diabetes complications. But not everyone benefits equally.

17 Sep 2025

New findings show lymph nodes educate T cells to combat disease

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against chronic infection and cancer.

17 Sep 2025

How to feasibly combine brief psychotherapy with medication visits

Abbreviated, 15- to 30-minute medication visits have become common in psychiatry now that many insurers model their reimbursement patterns on internal medicine and surgery.

16 Sep 2025

Researchers provide new insights into how exercise helps lose weight

Researchers at Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, Stanford University School of Medicine and collaborating institutions provide new insights into how exercise helps lose weight.

16 Sep 2025

Therapy News and Research

Daily orforglipron GLP-1 pill achieves over 11% weight loss in global obesity trial

Clinical trial reveals encouraging results for apitegromab in spinal muscular atrophy

Investigational drug reduces hot flashes and night sweats for post-menopausal women

Massage Therapy Foundation funds CHOP study on pediatric irritable bowel syndrome

Music therapy improves patient experience and outcomes in the cardiac ICU

New study uncovers why dispersed glioblastoma cells are more dangerous

University of Houston co-leads national study on atropine eyedrops for nearsightedness prevention

New molecule offers a more targeted and potent immunotherapy

Targeted radiation shows promise for rare solitary fibrous tumors

Implantable device helps stabilize blood pressure in spinal cord injury patients

Psoriasis linked to higher risk of age-related macular degeneration

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

The 15th AACR cancer progress report highlights scientific advances

The mind-gut connection: How emotional eating affects GLP-1 drug success

New findings show lymph nodes educate T cells to combat disease

How to feasibly combine brief psychotherapy with medication visits

Researchers provide new insights into how exercise helps lose weight

Leading cancer organizations release updated guideline on post-mastectomy radiation therapy

Researchers uncover how HIV-1 uses RNA:DNA hybrids to integrate into the genome

Stem cell therapy restores brain function after stroke

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News